Correlation of fecal metabolomics and gut microbiota in mice with endometriosis

被引:57
|
作者
Ni, Zhexin [1 ]
Sun, Shuai [1 ]
Bi, Yanli [1 ]
Ding, Jie [1 ]
Cheng, Wen [1 ]
Yu, Jin [1 ]
Zhou, Ling [1 ]
Li, Mingqing [2 ]
Yu, Chaoqin [1 ]
机构
[1] Naval Med Univ, Changhai Hosp, Dept Gynecol Tradit Chinese Med, Shanghai, Peoples R China
[2] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
endometriosis; intestines; metabolomics; microbiota; ALPHA-LINOLENIC ACID; INFLAMMATION; MARKERS; IMPACT; BILE;
D O I
10.1111/aji.13307
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Problem Endometriosis (EMS) is a chronic inflammatory disease with unclear pathogenesis. Three studies have uncovered the influence of gut microbiota on mice with EMS, but no study has investigated the characteristics of fecal metabolomics to determine some important clues on EMS. This research aims to uncover the interaction between fecal metabolomics and gut microbiota in EMS mice. Method of study Female C57BL/6J mice were used to construct the EMS model. Non-target metabolomics was applied to detect the fecal metabolites of EMS mice. The 16s rRNA sequencing was used for clarifying the composition of the gut microbiota. The functional characteristics of gut microbiota were analyzed using the PICRUSt. The receiver operator characteristic curve (ROC) analysis was utilized for determining the potential important differential metabolites, and the Spearman correlation coefficient was applied for expressing the correlation between the important differential metabolites and gut microbiota. Results A total of 156 named differential metabolites were screened. The diversity and the abundance of gut microbiota in EMS mice decreased. Eleven pathways were involved in the differential metabolites and the functional prediction of gut microbiota, among which the second bile acid biosynthesis and alpha-linolenic acid (ALA) metabolism were the significant enrichment pathways. The increased abundance of chenodeoxycholic and ursodeoxycholic acids and the decreased abundance of ALA and 12,13-EOTrE were found in the feces of EMS mice. Conclusion The abnormal fecal metabolites, which are influenced by dysbacteriosis, may be the characteristics of EMS mice and can be the potential important indices to distinguish the disease.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
    Quaranta, Gianluca
    Guarnaccia, Alessandra
    Fancello, Giovanni
    Agrillo, Chiara
    Iannarelli, Federica
    Sanguinetti, Maurizio
    Masucci, Luca
    MICROORGANISMS, 2022, 10 (12)
  • [32] Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Cammarota, Giovanni
    Ianiro, Gianluca
    Bibbo, Stefano
    Gasbarrini, Antonio
    INTERNAL AND EMERGENCY MEDICINE, 2014, 9 (04) : 365 - 373
  • [33] Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation?
    Giovanni Cammarota
    Gianluca Ianiro
    Stefano Bibbò
    Antonio Gasbarrini
    Internal and Emergency Medicine, 2014, 9 : 365 - 373
  • [34] Challenges of metabolomics in human gut microbiota research
    Smirnov, Kirill S.
    Maier, Tanja V.
    Walker, Alesia
    Heinzmann, Silke S.
    Forcisi, Sara
    Martinez, Ines
    Walter, Jens
    Schmitt-Kopplin, Philippe
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 306 (05) : 266 - 279
  • [35] Study on gut microbiota and metabolomics in postmenopausal women
    Xie, Xinyuan
    Song, Jinbin
    Wu, Yue
    Li, Mei
    Guo, Wenfeng
    Li, Shuang
    Li, Yanwu
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [36] Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice
    Quentin Le Bastard
    Tonya Ward
    Dimitri Sidiropoulos
    Benjamin M. Hillmann
    Chan Lan Chun
    Michael J. Sadowsky
    Dan Knights
    Emmanuel Montassier
    Scientific Reports, 8
  • [37] Goreisan-induced modulation of fecal bile acid composition and gut microbiota in mice
    Watanabe, Shiro
    Takahashi, Kyoka
    Awale, Suresh
    Furusawa, Yukihiro
    Tabuchi, Yoshiaki
    Nishidono, Yuto
    Tanaka, Ken
    TRADITIONAL & KAMPO MEDICINE, 2024, 11 (01) : 46 - 53
  • [38] Gut microbiota and obesity: implications for fecal microbiota transplantation therapy
    Yongbo Kang
    Yue Cai
    Hormones, 2017, 16 : 223 - 234
  • [39] Gut microbiota and obesity: implications for fecal microbiota transplantation therapy
    Kang, Yongbo
    Cai, Yue
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (03): : 223 - 234
  • [40]  Nanocapsule of gut microbiota for enhancing efficacy of fecal microbiota transplantation
    Hou, Weiliang
    Wang, Jifeng
    Yin, Fang
    Ma, Chunlian
    Wang, Jiahui
    Guo, Ning
    Li, Juanjuan
    Qin, Huanlong
    GUT, 2023, 72 (SUPPL_1) : A68 - A69